First Time Loading...
L

Lucid Diagnostics Inc
NASDAQ:LUCD

Watchlist Manager
Lucid Diagnostics Inc
NASDAQ:LUCD
Watchlist
Price: 0.95 USD 8.11% Market Closed
Updated: May 3, 2024
Section:
 

Wall Street
Price Targets

LUCD Price Targets Summary
Lucid Diagnostics Inc

Wall Street analysts forecast LUCD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for LUCD is 3.91 USD with a low forecast of 2.53 USD and a high forecast of 8.4 USD.

LUCD Lowest Forecast
Wall Street Target
2.53 USD
166% Upside
LUCD Average Forecast
Wall Street Target
3.91 USD
312% Upside
LUCD Highest Forecast
Wall Street Target
8.4 USD
784% Upside
Lowest
Price Target
2.53 USD
166% Upside
Average
Price Target
3.91 USD
312% Upside
Highest
Price Target
8.4 USD
784% Upside

LUCD Last Price Targets
Lucid Diagnostics Inc

The latest public price target was made on Apr 8, 2024 by Mark Massaro from BTIG , who expects LUCD stock to rise by 163% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Mark Massaro
BTIG
2.5 USD
Upside 163%
3 weeks ago
Apr 8, 2024
BTIG updates Lucid Diagnostics Inc (LUCD) model post Q4 results
StreetInsider
Mark Massaro
BTIG
Price Target 2.5 USD
Upside/Downside 163%
View Source
Lucid Diagnostics Inc Competitors:
Price Targets
0TN
Bioretec Oy
12% Upside
L
085370
Lutronic Corp
10% Downside
STE
STERIS plc
19% Upside
IPD
ImpediMed Ltd
123% Upside
0TN
Bioretec Oy
12% Upside
L
085370
Lutronic Corp
10% Downside
STE
STERIS plc
19% Upside
IPD
ImpediMed Ltd
123% Upside
BIM
Biomerieux SA
17% Upside
NSCI
Nanalysis Scientific Corp
199% Upside
J
287410
Jeisys Medical Inc
35% Upside
6951
JEOL Ltd
34% Upside

Revenue
Forecast

Revenue Estimate
Lucid Diagnostics Inc

The compound annual growth rate of Lucid Diagnostics Inc's revenue for the next 3 years is 168%.

N/A
Past Growth
168%
Estimated Growth
Estimates Accuracy
-3%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Lucid Diagnostics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Lucid Diagnostics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-25%
Average Miss
What are analyst estimates?

See Also

Summary
LUCD intrinsic value, competitors valuation, and company profile.
DCF Valuation
LUCD stock valuation using Discount Cash Flow valuation method.
Relative Valuation
LUCD stock valuation using valuation multiples.
Wall Street Estimates
LUCD price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
LUCD stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is LUCD's stock price target?
Price Target
3.91 USD

According to Wall Street analysts, the average 1-year price target for LUCD is 3.91 USD with a low forecast of 2.53 USD and a high forecast of 8.4 USD.

What is Lucid Diagnostics Inc's Revenue forecast?
Projected CAGR
168%

The compound annual growth rate of Lucid Diagnostics Inc's revenue for the next 3 years is 168%.

ALPHA SPREAD
Join more than 133,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.